Revenue Breakdown
Composition ()
No data
Revenue Streams
Utah Medical Products Inc (UTMD) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Gynecology/Electrosurgery/Urology, accounting for 48.3% of total sales, equivalent to $4.81M. Other significant revenue streams include Neonatal and Blood Pressure Monitoring and Accessories. Understanding this composition is critical for investors evaluating how UTMD navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Utah Medical Products Inc maintains a gross margin of 57.11%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 26.61%, while the net margin is 26.81%. These profitability ratios, combined with a Return on Equity (ROE) of 9.59%, provide a clear picture of how effectively UTMD converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, UTMD competes directly with industry leaders such as CRDF and SKIN. With a market capitalization of $200.81M, it holds a leading position in the sector. When comparing efficiency, UTMD's gross margin of 57.11% stands against CRDF's 100.00% and SKIN's 64.59%. Such benchmarking helps identify whether Utah Medical Products Inc is trading at a premium or discount relative to its financial performance.
